Accord BioPharma's Biosimilar Trastuzumab HLX02 BLA Accepted by US FDA

Accord BioPharma, the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on development of oncology, immunology, and critical care therapies, ...

April 06, 2023 | Thursday | News
Vertex, CRISPR submit BLAs to FDA for exa-cel in sickle cell and beta thalassemia

-EU and UK filings completed in 2022; submissions validated by EMA and MHRA and the review procedure has begun as of January 2023-   -Vertex Pharmac...

April 04, 2023 | Tuesday | News
Campbell Neurosciences Announces Novel Mechanistic Data on CampbellCell Stem Cell Therapy for Schizophrenia

Therapeutic Solutions International (TSOI) Spin Off Company Campbell Neurosciences announced new data, covered by its previously filed patents, demonstrati...

April 04, 2023 | Tuesday | News
The World's Second Approved Biosimilars of Denosumab (MAILISHU)

MAILISHU is the world's second approved Biosimilars of Denosumab for the osteoporosis in postmenopausal women at high risk of fracture. The drug can signif...

April 03, 2023 | Monday | News
Synthetic Periwinkle: Emulating Nature For Drug Discovery

With its resplendent flowers, the Madagascar periwinkle plant (Catharanthus roseus) easily draws attention to itself, both in a natural setting and in ...

April 01, 2023 | Saturday | Analysis
Novel Approaches for Engineering AAV Vectors for Gene Therapy

AAVs make ideal gene therapy vectors due to their small size, genetic simplicity, and low immunogenicity. However, several limitations are hindering the wi...

April 01, 2023 | Saturday | News
Using CRISPR-edited iPSCs to Understand Alzheimer’s Disease

More recently, the CRISPR system has been used to edit human induced pluripotent stem cells (iPSCs), which are known to exhibit phenotypes closer to human ...

April 01, 2023 | Saturday | Analysis
COVID-19 Infection Shown to Significantly Increase Drug Clearance of Therapeutic Monoclonal Antibodies

Patients with inflammatory diseases being treated with therapeutic monoclonal antibodies (mAbs) such as Infliximab may experience a significant increase in...

March 30, 2023 | Thursday | News
Thermo Fisher Scientific and Arsenal Biosciences Collaborate to Support Clinical Manufacturing of Autologous T-Cell Therapies

ArsenalBio recently advanced its lead product candidate into clinical manufacturing of its autologous integrated circuit T cell (ICT) therapy for...

March 29, 2023 | Wednesday | News
Thermo Fisher Scientific Opens Cell Therapy Facility at University of California, San Francisco

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and the University of California, San Francisco (UCSF), will accelerate adv...

March 28, 2023 | Tuesday | News
Sandoz announces agreement to acquire leading antifungal agent Mycamine® from Astellas

Sandoz plans to acquire worldwide product rights for Mycamine® (micafungin sodium) from Astellas Acquiring leading global echinocandin, one of three...

January 24, 2023 | Tuesday | News
Genomic Vision strengthens its management by welcoming Frédéric Hammel as Chief Operating Officer

Frédéric, a biologist by training (ENS, MBA from the College of Engineers), is a recognized leader, with more than 25 years of experience in ...

January 24, 2023 | Tuesday | News
PCR-based PoC Platforms for Infectious Disease Testing Growth Opportunities

The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respiratory tract pathogens are notewor...

January 24, 2023 | Tuesday | News
CytoSMART Technologies Joins the Axion BioSystems Brand

According to Axion CEO Kevin Gould, “Bringing all of our instruments under the Axion BioSystems umbrella helps ensure all of our customers receive th...

January 24, 2023 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close